Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors

被引:22
作者
Chonan, Tomomichi [1 ]
Tanaka, Hiroaki [1 ]
Yamamoto, Daisuke [2 ]
Yashiro, Miyoko [3 ]
Oi, Takahiro [1 ]
Wakasugi, Daisuke [1 ]
Ohoka-Sugita, Ayumi [2 ]
Io, Fusayo [2 ]
Koretsune, Hiroko [2 ]
Hiratate, Akira [1 ]
机构
[1] Taisho Pharmaceut Co Ltd, Med Chem Labs, Kita Ku, Saitama 3319530, Japan
[2] Taisho Pharmaceut Co Ltd, Mol Funct & Pharmacol Labs, Kita Ku, Saitama 3319530, Japan
[3] Taisho Pharmaceut Co Ltd, Res Comp Syst, Kita Ku, Saitama 3319530, Japan
关键词
Acetyl-CoA carboxylase; Inhibitor; (4-Piperidinyl)-piperazine; FATTY-ACID OXIDATION; MICE;
D O I
10.1016/j.bmcl.2010.04.134
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Acetyl-CoA carboxylases ( ACCs), the rate limiting enzymes in de novo lipid synthesis, play important roles in modulating energy metabolism. The inhibition of ACC has demonstrated promising therapeutic potential for treating obesity and type 2 diabetes mellitus in transgenic mice and preclinical animal models. We describe herein the structure-based design and synthesis of a novel series of disubstituted ( 4-piperidinyl)-piperazine derivatives as ACC inhibitors. Our structure-based approach led to the discovery of the indole derivatives 13i and 13j, which exhibited potent in vitro ACC inhibitory activity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3965 / 3968
页数:4
相关论文
共 9 条
[1]   Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 [J].
Abu-Elheiga, L ;
Matzuk, MM ;
Abo-Hashema, KAH ;
Wakil, SJ .
SCIENCE, 2001, 291 (5513) :2613-2616
[2]  
ANNE M, 1987, J CLIN INVEST, V79, P59
[3]   (4-Piperidinyl)-piperazine: A new platform for acetyl-CoA carboxylase inhibitors [J].
Chonan, Tomomichi ;
Oi, Takahiro ;
Yamamoto, Daisuke ;
Yashiro, Miyoko ;
Wakasugi, Daisuke ;
Tanaka, Hiroaki ;
Ohoka-Sugita, Ayumi ;
Io, Fusayo ;
Koretsune, Hiroko ;
Hiratate, Akira .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) :6645-6648
[4]  
Corbett Jeffrey W, 2007, Recent Pat Cardiovasc Drug Discov, V2, P162, DOI 10.2174/157489007782418928
[5]   Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice [J].
Harada, Naomoto ;
Oda, Zenjun ;
Hara, Yoshikazu ;
Fujinami, Koji ;
Okawa, Mayumi ;
Ohbuchi, Katsuya ;
Yonemoto, Mari ;
Ikeda, Yuika ;
Ohwaki, Kenji ;
Aragane, Katsumi ;
Tamai, Yoshitaka ;
Kusunoki, Jun .
MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (05) :1881-1888
[6]   Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition [J].
Harwood, HJ .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (02) :267-281
[7]   Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals [J].
Harwood, HJ ;
Petras, SF ;
Shelly, LD ;
Zaccaro, LM ;
Perry, DA ;
Makowski, MR ;
Hargrove, DM ;
Martin, KA ;
Tracey, WR ;
Chapman, JG ;
Magee, WP ;
Dalvie, DK ;
Soliman, VF ;
Martin, WH ;
Mularski, CJ ;
Eisenbeis, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37099-37111
[8]  
ISLER O, 1955, HELV CHIM ACTA, V118, P1033
[9]   Crystal structure of the carboxyltransferase domain of acetyl-coenzyme a carboxylase [J].
Zhang, HL ;
Yang, ZR ;
Shen, Y ;
Tong, L .
SCIENCE, 2003, 299 (5615) :2064-2067